TRAF6 distinctively mediates MyD88- and IRAK-1-induced activation of NF-κB
- 10 December 2007
- journal article
- Published by Oxford University Press (OUP) in Journal of Leukocyte Biology
- Vol. 83 (3) , 702-707
Abstract
MyD88 and IL-1R-associated kinase 1 (IRAK-1) play crucial roles as adaptor molecules in signal transduction of the TLR/IL-1R superfamily, and it is known that expression of these proteins leads to the activation of NF-κB in a TNFR-associated factor 6 (TRAF6)-dependent manner. We found in this study, however, that a dominant-negative mutant of TRAF6, lacking the N-terminal RING and zinc-finger domain, did not inhibit IRAK-1-induced activation of NF-κB in human embryonic kidney 293 cells, although the TRAF6 mutant strongly suppressed the MyD88-induced activation. The dominant-negative mutant of TRAF6 did not affect the IRAK-1-induced activation, regardless of the expression level of IRAK-1. In contrast, small interfering RNA silencing of TRAF6 expression inhibited MyD88-induced and IRAK-1-induced activation, and supplementation with the TRAF6 dominant-negative mutant did not restore the IRAK-1-induced activation. Expression of IRAK-1, but not MyD88, induced the oligomerization of TRAF6, and IRAK-1 and the TRAF6 dominant-negative mutant were associated with TRAF6. These results indicate that TRAF6 is involved but with different mechanisms in MyD88-induced and IRAK-induced activation of NF-κB and suggest that TRAF6 uses a distinctive mechanism to activate NF-κB depending on signals.Keywords
Funding Information
- Ministry of the Environment
This publication has 22 references indexed in Scilit:
- Ubiquitin signalling in the NF-κB pathwayNature Cell Biology, 2005
- Signaling to NF-κBGenes & Development, 2004
- Molecular mechanisms of macrophage activation and deactivation by lipopolysaccharide: roles of the receptor complexPharmacology & Therapeutics, 2003
- Functional Diversity and Regulation of Different Interleukin-1 Receptor-Associated Kinase (IRAK) Family MembersMolecular Cell, 2003
- Inhibition of Interleukin 1 Receptor/Toll-like Receptor Signaling through the Alternatively Spliced, Short Form of MyD88 Is Due to Its Failure to Recruit IRAK-4Journal of Experimental Medicine, 2003
- Distinct molecular mechanism for initiating TRAF6 signallingNature, 2002
- IRAK-4: A novel member of the IRAK family with the properties of an IRAK-kinaseProceedings of the National Academy of Sciences, 2002
- IL-1-induced NFκB and c-Jun N-terminal kinase (JNK) activation diverge at IL-1 receptor-associated kinase (IRAK)Proceedings of the National Academy of Sciences, 2001
- IRAK (Pelle) Family Member IRAK-2 and MyD88 as Proximal Mediators of IL-1 SignalingScience, 1997
- TRAF6 is a signal transducer for interleukin-1Nature, 1996